Epidemiological profile of breast cancer mortality in the state of Mato de Grosso, Brazil, from 2011 to 2021
DOI:
https://doi.org/10.33448/rsd-v12i7.42595Keywords:
Epidemiology; Breast cancer; Incidence; Mortality; Neoplasms.Abstract
Objective: To analyze and describe the epidemiological profile of breast cancer mortality in the State of Mato Grosso (MT), Brazil, from 2011 to 2021. Methodology: The data were collected from the Mato Grosso State Health Secretariat Portal and analyzed using Microsoft Excel 2016 and SPSS software. Result: A significant increase of 60% in the number of deaths from breast cancer in MT over the study period. In 2021, there was the highest absolute frequency (11.2%), with females being the most affected (98.3%). The age groups of 50 to 59 years, 60 to 69 years, and 40 to 49 years together accounted for 66.6% of deaths. The brown race represented 49.8% of the deaths, and individuals with 8 to 11 years of education had the highest mortality rate (25.9%). The underlying cause of unspecified breast cancer classification represented 85% of the deaths, and 75% of the victims received medical assistance. Notably, 96.1% of the deaths due to breast cancer did not have an outpatient investigation. The Central-North macro-region, including the city of Cuiabá, accounted for 51.8% of the deaths. Occupations in Group 4 and 5 accounted for 72.9% of breast cancer deaths. Conclusion: Breast cancer mortality in MT exhibits peculiarities compared to the national reality, particularly in terms of race/color and years of education, due to socioeconomic factors and the natural history of the disease. However, most of the analyzed variables showed a similar mortality trend to breast cancer epidemiology in Brazil.
References
Alves, J., Pereira, A. & Santos, R. (2022). Fisiopatologia e Fatores de Risco Associados ao Câncer de Mama. Braz. J. Case Rep. 6 (2), 18-19.
Andrade, M. M. D. D. (2010). Introdução à metodologia do trabalho científico. In Introdução à metodologia do trabalho científico,158-158.
Bedognetti, D. et al. (2016). Checkpoint Inhibitors and Their Application in Breast Cancer. BC, 11 (2), 108-115.
Bergenfelz, C., Gaber, A., Allaoui, R., Mehmeti, M., Jirström, K., Leanderson, T., & Leandersson, K. (2015). S100A9 expressed in ER− PgR− breast cancers induces inflammatory cytokines and is associated with an impaired overall survival. Br J Cancer, 113(8), 1234-1243.
Brasil. Ministério da Saúde. Secretária de Vigilância em Saúde (2020). Mortalidade por câncer de mama no Brasil: 2010-2018. Boletim Epidemiológico, 45 (51), 1-7.
Couto, M. S. D. A., Guerra, M. R., Firme, V. D. A. C., & Bustamante-Teixeira, M. T. (2018). Comportamento da mortalidade por câncer de mama nos municípios brasileiros e fatores associados. Rev Panam Salud Publica, 41, 168.
Dutra, L. S., Ferreira, A. P., Horta, M. A. P., & Palhares, P. R. (2021). Uso de agrotóxicos e mortalidade por câncer em regiões de monoculturas. S. e D, 44 (127), 1018-1035.
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Artes Médicas.
França, E., Teixeira, R., Ishitani, L., Duncan, B. B., Cortez-Escalante, J. J., Morais Neto, O. L. D., & Szwarcwald, C. L. (2014). Causas mal definidas de óbito no Brasil: método de redistribuição baseado na investigação do óbito. Revista de Saúde Pública, 48 (4), 671-681.
Gusso, G., & Lopes, J. M. C. (2018). Tratado de Medicina de Família e Comunidade-: Princípios, Formação e Prática. Artes Medicas.
Hinchliffe, A., Kogevinas, M., Pérez-Gómez, B., Ardanaz, E., Amiano, P., Marcos-Delgado, A., ... & Turner, M. C. (2021). Occupational heat exposure and breast cancer risk in the MCC-Spain study. Cancer Epidemiol, Biomarkers Prev, 30 (2), 364-372.
INCA. (2019). A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação.
Kumar, V., Abbas, A. K., Fausto, N., & Mitchell, R. N. (2008). Robbins patologia básica. Elsevier Brasil.
Lee, J. J., Loh, K., & Yap, Y. S. (2015). PI3K/Akt/mTOR inhibitors in breast cancer. Cancer Biol Med, 12 (4), 342.
Livraghi, L., & Garber, J. E. (2015). PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med, 13 (1), 1-16.
Ly, D., Forman, D., Ferlay, J., Brinton, L. A., & Cook, M. B. (2013). An international comparison of male and female breast cancer incidence rates. Int. J. Cancer, 132 (8), 1918-1926.
Modesto, V. C., Evangelista, F. D. M., Soares, M. R., Alves, M. R., Neves, M. A. B. D., Corrêa, M. L. M., ... & Andrade, A. C. D. S. (2022). Mortalidade por câncer no estado de Mato Grosso, Brasil, no período de 2000 a 2015: tendência temporal e diferenças regionais. Rev. Bras. Epidemiol, 25 (1).
Rosa, L. M. D., & Radünz, V. (2012). Taxa de sobrevida na mulher com câncer de mama: estudo de revisão. Texto & Contexto Enferm, 21, 980-989.
Silva, N. R. O. (2021). Mortalidade por câncer de mama no Brasil de 2010 a 2019. Rev. Cient. Multidisc. Núc. Conhe., 13 (03), 116–125.
Soares, L. R., Gonzaga, C. M. R., Branquinho, L. W., Sousa, A. L. L., Souza, M. R., & Freitas-Junior, R. (2015). Mortalidade por câncer de mama feminino no Brasil de acordo com a cor. Bras. Ginecol. Obstet, 37, 388-392.
Spreafico, F. S., Cardoso-Filho, C., Cabello, C., Sarian, L. O., Zeferino, L. C., & Vale, D. B. (2020). Breast cancer in men: clinical and pathological analysis of 817 cases. Am J Mens Health, 14 (4), 1557988320908109.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71 (3), 209-249.
Wild, C. P., Weiderpass, E., Stewart, B. W. (2020). World cancer report. Cancer Research for Cancer Prevention.
Wilkinson, L., & Gathani, T. (2022). Understanding breast cancer as a global health concern. Br J Radiol, 95 (1130), 20211033.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Gustavo Bruno Martins de Siqueira ; Rayane Manoel Garcia; Vanessa de Almeida Raia; Luiz Eduardo Alessio Junior ; Aline Morandi Alessio
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
